Key result
Homozygous and heterozygous FH had higher aortic stenosis prevalence than the general population, with AVR rates of 5.89, 1.56, and 0.18 per 1,000 patient-years.
Why the study?
Homozygous familial hypercholesterolemia is associated with severe aortic stenosis requiring complex aortic valve replacement, prompting a systematic review to characterize aortic stenosis prevalence and aortic valve replacement incidence across homozygous and heterozygous familial hypercholesterolemia compared with the general population.
Meta-Analysis
Patients with familial hypercholesterolemia exhibit a marked, graded increase in aortic stenosis prevalence and aortic valve replacement incidence compared to the general population, particularly in homozygous FH.
Answers are grounded in this paper and cite their sources.
Elevated AS burden in HoFH may warrant targeted screening; confirms and quantifies excess risk versus HeFH and general population.
Aims Familial hypercholesterolemia (FH) is characterized by lifelong exposure to elevated LDL-C and premature atherosclerotic cardiovascular disease (ASCVD). The homozygous form (HoFH) is associated with severe aortic stenosis (AS), often requiring complex aortic valve replacement (AVR). Our aim was to conduct a systematic review (PROSPERO-CRD42024611618) to characterize the prevalence of AS and incidence of AVR in HoFH and heterozygous FH (HeFH) compared with the general population. Methods MEDLINE, Embase, Cochrane Central, PubMed, Web of Science, Scopus and BIOSIS were searched from inception to 25 September 2025 for studies reporting AS prevalence and AVR incidence in FH and the general population. Results Among 2024 unique records identified, 53 studies met eligibility criteria. In cohorts with a mean age ≤75 years, the pooled prevalence of mild-to-severe AS was significantly higher in HoFH (32.7%; 95%CI: 26.0-40.2%; n=18 studies) and HeFH (3.4%; 95%CI: 1.5%-7.6%; n=7) compared with the general population (0.9%; 95%CI: 0.5%-1.4%; n=7) ( p <0.0001 for both comparisons). The AS prevalence was also significantly higher in HoFH than HeFH ( p <0.0001). The AVR incidence was 5.89, 1.56 and 0.18 AVR per 1,000 patient-years in HoFH, HeFH and in the general population, respectively. Conclusion A marked and graded increase in AS burden was observed across HoFH, HeFH, and the general population, with particularly high prevalence of AS and AVR rates in HoFH at relatively young ages. These findings extend the recognized cardiovascular phenotype of FH beyond ASCVD and highlight the importance of early and sustained lipid-lowering therapy to reduce LDL-C exposure and mitigate long-term valvular complications.
No takes yet. Share an insight, caveat, or question.
Erzingatzian et al. (2026) conducted a meta-analysis in Familial hypercholesterolemia (HoFH and HeFH) and aortic stenosis. Homozygous and heterozygous familial hypercholesterolemia (HoFH and HeFH) vs. General population was evaluated on Pooled prevalence of mild-to-severe aortic stenosis (and incidence of aortic valve replacement) (95% CI 26.0-40.2, p=<0.0001). Homozygous and heterozygous FH had higher aortic stenosis prevalence than the general population, with AVR rates of 5.89, 1.56, and 0.18 per 1,000 patient-years.
Synapse has enriched 10 related papers. Consider them for comparative context: